A Pharmacokinetic Study to Evaluate TREXIMET in Adolescents With Migraine and Healthy Subjects Administered at Three Doses.
Status:
Completed
Trial end date:
2009-09-10
Target enrollment:
Participant gender:
Summary
This is a pharmacokinetic (PK) study designed to investigate a combination product containing
sumatriptan succinate and naproxen sodium administered at 3 single doses (10mg
sumatriptan/60mg naproxen sodium, 30mg sumatriptan/180mg naproxen sodium, 85mg
sumatriptan/500mg naproxen sodium) in adolescent migraine patients. The same doses will be
also administered to a group of healthy volunteer (HV) adult subjects and the PK parameters
will be compared between these two groups and between doses.